Managers / Q4 2025 · view latest →
Accent Capital Management, LLC
CIK 0002014179 · 170 E. SPRING VALLEY PIKE, SUITE B, CENTERVILLE, OH, 45458 · 937-231-0528
Summary
Accent Capital Management, LLC reported $233M in U.S.-listed holdings across 354 positions for Q4 2025.
Its largest position, GOOG, represents 12.4% of the portfolio.
Compared with Q3 2025, the fund opened 17 new positions and exited 42.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 87.4% · $203M
- ETP · 11.2% · $26M
- ADR · 1.1% · $2M
- Other · 0.4% · $842,604
- REIT · 0.0% · $49,441
Quarter-over-Quarter Changes full breakdown →
vs Q3 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BERKSHIRE HATHAWAY B | NEW | +437 | 437 | +$219,658 | $219,658 |
| ASHGYASHTEAD GROUP PLC ADR | NEW | +788 | 788 | +$55,743 | $55,743 |
| SOLSSOLSTICE ADVANCED MA | NEW | +1.0K | 1.0K | +$50,912 | $50,912 |
| IHEISHARES US PHARMACEUTICALS ETF | NEW | +500 | 500 | +$42,415 | $42,415 |
| PRAXPRAXIS PRECISION MED | NEW | +50 | 50 | +$14,737 | $14,737 |
| KYMRKYMERA THERAPEUTICS | NEW | +150 | 150 | +$11,672 | $11,672 |
| NPPEYNIPPON ELECTRIC GL | NEW | +300 | 300 | +$11,067 | $11,067 |
| LTMLATAM AIRLINES GROUP ADR | NEW | +200 | 200 | +$10,802 | $10,802 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $206M | 338 | May 11, 2026 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2025 | $233M | 354 | Feb 9, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $238M | 380 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $224M | 403 | Aug 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $173M | 326 | May 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $176M | 191 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $174M | 210 | Nov 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $163M | 182 | Aug 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $116M | 170 | May 13, 2024 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.